Kamran Alam - Net Worth and Insider Trading
Kamran Alam Net Worth
The estimated net worth of Kamran Alam is at least $774,126 dollars as of 2024-11-29. Kamran Alam is the CFO of Taysha Gene Therapies Inc and owns about 258,042 shares of Taysha Gene Therapies Inc (TSHA) stock worth over $774,126. Details can be seen in Kamran Alam's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kamran Alam has not made any transactions after 2023-08-24 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kamran Alam
Kamran Alam Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kamran Alam owns 2 companies in total, including Taysha Gene Therapies Inc (TSHA) , and Rocket Pharmaceuticals Inc (RCKT) .
Click here to see the complete history of Kamran Alam’s form 4 insider trades.
Insider Ownership Summary of Kamran Alam
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-08-24 | Chief Financial Officer |
| RCKT | Rocket Pharmaceuticals Inc | 2019-10-28 | SVP - Finance & PFO |
Kamran Alam Latest Holdings Summary
Kamran Alam currently owns a total of 1 stock. Kamran Alam owns 258,042 shares of Taysha Gene Therapies Inc (TSHA) as of August 24, 2023, with a value of $774,126.
Latest Holdings of Kamran Alam
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSHA | Taysha Gene Therapies Inc | 2023-08-24 | 258,042 | 3.00 | 774,126 |
Holding Weightings of Kamran Alam
Kamran Alam Form 4 Trading Tracker
According to the SEC Form 4 filings, Kamran Alam has made a total of 4 transactions in Taysha Gene Therapies Inc (TSHA) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Taysha Gene Therapies Inc is the sale of 33,000 shares on August 24, 2023, which brought Kamran Alam around $76,890.
Insider Trading History of Kamran Alam
- 1
Kamran Alam Trading Performance
Kamran Alam Ownership Network
Kamran Alam Owned Company Details
What does Taysha Gene Therapies Inc do?
Who are the key executives at Taysha Gene Therapies Inc?
Kamran Alam is the Chief Financial Officer of Taysha Gene Therapies Inc. Other key executives at Taysha Gene Therapies Inc include director & 10 percent owner Paul B Manning , 10 percent owner Session R.a. Ii , and 10 percent owner Astellas Pharma Inc. .
Taysha Gene Therapies Inc (TSHA) Insider Trades Summary
Over the past 18 months, Kamran Alam made 1 insider transaction in Taysha Gene Therapies Inc (TSHA) with a net sale of 33,000. Other recent insider transactions involving Taysha Gene Therapies Inc (TSHA) include a net purchase of 17,900,000 shares made by Paul B Manning , a net sale of 549,095 shares made by Session R.a. Ii , and a net purchase of 777,778 shares made by Stalfort John A Iii .
In summary, during the past 3 months, insiders sold 0 shares of Taysha Gene Therapies Inc (TSHA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 582,095 shares of Taysha Gene Therapies Inc (TSHA) were sold and 19,233,333 shares were bought by its insiders, resulting in a net purchase of 18,651,238 shares.
Taysha Gene Therapies Inc (TSHA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Taysha Gene Therapies Inc Insider Transactions
Kamran Alam Mailing Address
Above is the net worth, insider trading, and ownership report for Kamran Alam. You might contact Kamran Alam via mailing address: 350 Fifth Avenue, Suite 7530, New York Ny 10118.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
